ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,122Medicare Part D Prescriptions Filled, Including Refills
$956K Total Retail Price of All Prescriptions
467 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 565 513
LISINOPRIL 337 294
ADVAIR DISKUS 319 267
AMLODIPINE BESYLATE 302 272
LEVOTHYROXINE SODIUM 285 256
ATORVASTATIN CALCIUM 223 219
SPIRIVA 185 181
METOPROLOL SUCCINATE 180 176
HYDROCHLOROTHIAZIDE 171 152
ALBUTEROL SULFATE 169 136
PROAIR HFA 162 119
METOPROLOL TARTRATE 147 144
PREDNISONE 145 122
METFORMIN HCL ER 137 123
METFORMIN HCL 135 123
ATENOLOL 129 124
SPIRONOLACTONE-HCTZ 129 129
OMEPRAZOLE 123 113
WARFARIN SODIUM 121 95
PRAVASTATIN SODIUM 120 83
GLIMEPIRIDE 116 102
SINGULAIR 114 83
PANTOPRAZOLE SODIUM 108 55
COMBIVENT 102 90
ALENDRONATE SODIUM 92 92
ALLOPURINOL 89 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 82
ACTOS 88 86
FUROSEMIDE 87 84
JANUVIA 87 87
GABAPENTIN 79 66
POTASSIUM CHLORIDE 78 67
KLOR-CON M20 78 74
THEOPHYLLINE ANHYDROUS 77 60
MONTELUKAST SODIUM 74 55
DULERA 70 63
DONEPEZIL HCL 69 69
SERTRALINE HCL 67 67
SPIRONOLACTONE 66 66
DIGOXIN 65 60
LOSARTAN POTASSIUM 63 63
THEOPHYLLINE 62 38
VYTORIN 57 48
TRICOR 56 45
PAROXETINE HCL 56 51
NEXIUM 56 47
CLOPIDOGREL 56 56
GEMFIBROZIL 55 55
FLUOXETINE HCL 55 50
NASONEX 54 54
CARVEDILOL 52 48
HYDROCODONE-ACETAMINOPHEN 52 51 S3
ZETIA 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.